ketoconazole has been researched along with Addiction, Opioid in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
" To explore the treatment implications of these findings, ketoconazole's (600-900 mg daily) ability to reduce heroin and cocaine use was compared with placebo in 39 methadone maintained patients with a history of cocaine abuse or dependence during a 12-week double blind trial." | 5.10 | Ketoconazole increases cocaine and opioid use in methadone maintained patients. ( Feingold, A; Gonsai, K; Kosten, TR; Oliveto, A; Sevarino, KA, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kosten, TR | 1 |
Oliveto, A | 1 |
Sevarino, KA | 1 |
Gonsai, K | 1 |
Feingold, A | 1 |
1 trial available for ketoconazole and Addiction, Opioid
Article | Year |
---|---|
Ketoconazole increases cocaine and opioid use in methadone maintained patients.
Topics: Analysis of Variance; Antifungal Agents; Chi-Square Distribution; Cocaine-Related Disorders; Double- | 2002 |